# Yi Zhang

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/yi-zhang/

## Facts

| Field | Value |
| --- | --- |
| Citations | 99,624 |
| Field | Cancer Immunotherapy and Biomarkers |
| h-index | 105 |
| i10-index | 949 |
| Last Known Institution | Tianjin Medical University General Hospital |
| OpenAlex ID | https://openalex.org/A5100388089 |
| ORCID iD | 0000-0001-9861-4681 |
| Works | 2,211 |

## Researcher papers

- [Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study](https://scholariq.org/papers/clinical-course-and-risk-factors-for-mortality-of-adult-inpatients-with-covid-19/)
- [A Trial of Lopinavir–Ritonavir in Adults Hospitalized with Severe Covid-19](https://scholariq.org/papers/a-trial-of-lopinavir-ritonavir-in-adults-hospitalized-with-severe-covid-19/)
- [The Role of Tumoral FOXP3 on Cell Proliferation, Migration, and Invasion in Gastric Cancer](https://scholariq.org/papers/the-role-of-tumoral-foxp3-on-cell-proliferation-migration-and-invasion-in/)
- [Remdesivir in adults with severe COVID-19: a randomised, double-blind, placebo-controlled, multicentre trial](https://scholariq.org/papers/remdesivir-in-adults-with-severe-covid-19-a-randomised-double-blind-placebo/)
- [Roles of IFN-γ in tumor progression and regression: a review](https://scholariq.org/papers/roles-of-ifn-in-tumor-progression-and-regression-a-review/)
- [COVID-19: immunopathogenesis and Immunotherapeutics](https://scholariq.org/papers/covid-19-immunopathogenesis-and-immunotherapeutics/)
- [Immunosenescence: molecular mechanisms and diseases](https://scholariq.org/papers/immunosenescence-molecular-mechanisms-and-diseases/)
- [Tumor-associated macrophages: from basic research to clinical application](https://scholariq.org/papers/tumor-associated-macrophages-from-basic-research-to-clinical-application/)
- [SARS-CoV-2 binds platelet ACE2 to enhance thrombosis in COVID-19](https://scholariq.org/papers/sars-cov-2-binds-platelet-ace2-to-enhance-thrombosis-in-covid-19/)
- [Biomedical Applications of Zinc Oxide Nanomaterials](https://scholariq.org/papers/biomedical-applications-of-zinc-oxide-nanomaterials/)
- [Effects of a transitional home-based care program for stroke survivors in Harbin, China: a randomized controlled trial](https://scholariq.org/papers/effects-of-a-transitional-home-based-care-program-for-stroke-survivors-in-harbin/)

## Researcher topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [CAR-T cell therapy research](https://scholariq.org/topics/car-t-cell-therapy-research/)
- [Immune Cell Function and Interaction](https://scholariq.org/topics/immune-cell-function-and-interaction/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)
- [MicroRNA in disease regulation](https://scholariq.org/topics/microrna-in-disease-regulation/)

## Researcher university

- [Tianjin Medical University General Hospital](https://scholariq.org/institutions/tianjin-medical-university-general-hospital/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.